Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-080981
Filing Date
2025-08-20
Accepted
2025-08-20 17:20:14
Documents
1
Period of Report
2025-08-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2523925-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2523925-1_4seq1.xml 4 8530
  Complete submission text file 0001104659-25-080981.txt   10090
Mailing Address 1 GREENWICH OFFICE PARK GREENWICH CT 06831
Business Address (203) 413-2200
Hoffman Michael B (Reporting) CIK: 0001290208 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39202 | Film No.: 251237761

Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)